{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:59:04Z","timestamp":1773892744660,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2308085MH269"],"award-info":[{"award-number":["2308085MH269"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["YQZD2024028"],"award-info":[{"award-number":["YQZD2024028"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.yexcr.2025.114839","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T15:59:37Z","timestamp":1763827177000},"page":"114839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fbxo45 promotes cell viability, invasion and sunitinib resistance of clear cell renal cell carcinoma by targeting Erbin"],"prefix":"10.1016","volume":"454","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8504-9500","authenticated-orcid":false,"given":"Xueshan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiewen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114839_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.yexcr.2025.114839_bib2","first-page":"64","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.yexcr.2025.114839_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5507\/bp.2015.050","article-title":"Renal cell carcinoma: review of etiology, pathophysiology and risk factors","volume":"160","author":"Petejova","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.yexcr.2025.114839_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yexcr.2025.114839_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12885-019-5291-3","article-title":"DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma","volume":"19","author":"Evelonn","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2025.114839_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2018.09.016","article-title":"Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: an individualized approach to metastatic renal cell carcinoma","volume":"75","author":"Bhindi","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.yexcr.2025.114839_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fgene.2019.00439","article-title":"Whole-exome sequencing identifies somatic mutations associated with mortality in metastatic clear cell kidney carcinoma","volume":"10","author":"Mendoza-Alvarez","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.yexcr.2025.114839_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrm.2017.83","article-title":"Ubiquitylation at the crossroads of development and disease","volume":"19","author":"Rape","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114839_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrc.2017.105","article-title":"Ubiquitin ligases in oncogenic transformation and cancer therapy","volume":"18","author":"Senft","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2025.114839_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2022.11.002","article-title":"Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy","volume":"87","author":"Wang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2025.114839_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004049","article-title":"The roles of post-translational modifications in the context of protein interaction networks","volume":"11","author":"Duan","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.yexcr.2025.114839_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.semcancer.2022.06.004","article-title":"Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy","volume":"86","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2025.114839_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123244","article-title":"The E3 ubiquitin ligases regulate PD-1\/PD-L1 protein levels in tumor microenvironment to improve immunotherapy","volume":"14","author":"Hou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114839_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc3700","article-title":"Roles of F-box proteins in cancer","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2025.114839_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100673","article-title":"Emerging roles of F-box proteins in cancer drug resistance","volume":"49","author":"Yan","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.yexcr.2025.114839_bib16","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/MCB.00364-09","article-title":"Fbxo45 forms a novel ubiquitin ligase complex and is required for neuronal development","volume":"29","author":"Saiga","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114839_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature02647","article-title":"An SCF-like ubiquitin ligase complex that controls presynaptic differentiation","volume":"430","author":"Liao","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114839_bib18","doi-asserted-by":"crossref","first-page":"13897","DOI":"10.1074\/jbc.RA118.002176","article-title":"PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2","volume":"293","author":"Desbois","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114839_bib19","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/cdd.2014.104","article-title":"Fbxo45 joins the \u2018Par-4\u2019ty in controlling apoptosis of cancer cells","volume":"21","author":"Wang","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2025.114839_bib20","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/onc.2009.177","article-title":"The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73","volume":"28","author":"Peschiaroli","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2025.114839_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41420-020-0291-2","article-title":"FBXO45 is a potential therapeutic target for cancer therapy","volume":"6","author":"Lin","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2025.114839_bib22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/cdd.2014.92","article-title":"Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival","volume":"21","author":"Chen","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2025.114839_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41418-019-0385-7","article-title":"FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation","volume":"27","author":"Richter","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2025.114839_bib24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00432-018-2653-1","article-title":"Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma","volume":"144","author":"Wang","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2025.114839_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.21873\/anticanres.11305","article-title":"Low expression of FBXO45 is associated with gastric cancer progression and poor prognosis","volume":"37","author":"Kogure","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexcr.2025.114839_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.115.100925","article-title":"The dual estrogen receptor \u03b1 inhibitory effects of the tissue-selective estrogen complex for endometrial and breast safety","volume":"89","author":"Han","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114839_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/138920310794557673","article-title":"Erbin, a negative regulator in diverse signal pathways","volume":"11","author":"Liu","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.yexcr.2025.114839_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/35017038","article-title":"ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2\/HER2 receptor","volume":"2","author":"Borg","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114839_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2013.04.007","article-title":"Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance","volume":"56","author":"Liu","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.yexcr.2025.114839_bib30","doi-asserted-by":"crossref","first-page":"E4429","DOI":"10.1073\/pnas.1407139111","article-title":"Role of Erbin in ErbB2-dependent breast tumor growth","volume":"111","author":"Tao","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexcr.2025.114839_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2019.06.014","article-title":"PDS5B regulates cell proliferation and motility via upregulation of Ptch2 in pancreatic cancer cells","volume":"460","author":"Ma","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114839_bib32","first-page":"68","article-title":"Elevated FBXL6 activates both wild-type KRAS and mutant KRAS(G12D) and drives HCC tumorigenesis via the ERK\/mTOR\/PRELID2\/ROS axis in mice","volume":"10","author":"Xiong","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.yexcr.2025.114839_bib33","first-page":"19","article-title":"N(6)-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance","volume":"9","author":"Lin","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.yexcr.2025.114839_bib34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10495-022-01764-7","article-title":"CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K\/AKT\/mTOR pathways in glioma","volume":"27","author":"Cao","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2025.114839_bib35","first-page":"25","article-title":"Aspartoacylase suppresses prostate cancer progression by blocking LYN activation","volume":"10","author":"Weng","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.yexcr.2025.114839_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133204","article-title":"The insulin-like growth factor 2 mRNA binding protein IMP2\/IGF2BP2 is overexpressed and correlates with poor survival in pancreatic cancer","volume":"20","author":"Dahlem","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114839_bib37","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1074\/jbc.M109.046284","article-title":"Fbxo45, a novel ubiquitin ligase, regulates synaptic activity","volume":"285","author":"Tada","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114839_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70715","article-title":"Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation","volume":"10","author":"Lin","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.yexcr.2025.114839_bib39","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/1878-0261.13290","article-title":"Fbxo45-mediated NP-STEP46 degradation via K6-linked ubiquitination sustains ERK activity in lung cancer","volume":"16","author":"Wang","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.yexcr.2025.114839_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41419-022-04675-2","article-title":"Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114839_bib41","doi-asserted-by":"crossref","first-page":"28448","DOI":"10.1074\/jbc.M114.561241","article-title":"Fbxo45 inhibits calcium-sensitive proteolysis of N-cadherin and promotes neuronal differentiation","volume":"289","author":"Chung","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114839_bib42","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1038\/s41388-022-02468-7","article-title":"Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation","volume":"41","author":"Wang","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2025.114839_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2015.10.003","article-title":"F-box proteins: keeping the epithelial-to-mesenchymal transition (EMT) in check","volume":"36","author":"Diaz","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2025.114839_bib44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.18632\/oncotarget.2825","article-title":"Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2025.114839_bib45","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jhep.2017.01.030","article-title":"Elevated expression of Erbin destabilizes ERalpha protein and promotes tumorigenesis in hepatocellular carcinoma","volume":"66","author":"Wu","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2025.114839_bib46","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1158\/0008-5472.CAN-17-3629","article-title":"Erbin suppresses KSR1-Mediated RAS\/RAF signaling and tumorigenesis in colorectal cancer","volume":"78","author":"Stevens","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114839_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/path.4502","article-title":"Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR","volume":"236","author":"Yao","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2025.114839_bib48","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1038\/oncsis.2013.18","article-title":"Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner","volume":"2","author":"Hu","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.yexcr.2025.114839_bib49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2015.05.071","article-title":"Erbin loss promotes cancer cell proliferation through feedback activation of Akt-Skp2-p27 signaling","volume":"463","author":"Huang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2025.114839_bib50","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1158\/0008-5472.CAN-16-1970","article-title":"A naturally generated decoy of the prostate apoptosis Response-4 protein overcomes therapy resistance in tumors","volume":"77","author":"Hebbar","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114839_bib51","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jb\/mvn032","article-title":"Erbin-regulated sensitivity of MCF-7 breast cancer cells to TRAIL via ErbB2\/AKT\/NF-kappaB pathway","volume":"143","author":"Liu","year":"2008","journal-title":"J. Biochem."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725004392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725004392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:34:26Z","timestamp":1773884066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725004392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0014482725004392"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114839","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fbxo45 promotes cell viability, invasion and sunitinib resistance of clear cell renal cell carcinoma by targeting Erbin","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114839"}}